In this article, we will discuss the 10 Most Promising Penny Stocks According to Wall Street Analysts.
On May 29, Chris Retzler, Needham Small Cap Growth Fund portfolio manager, appeared on CNBC’s ‘Squawk Box’ to discuss the latest market trends and what’s driving the rally in small caps. When asked if small caps are just beginning to run, Retzler contrasted the current environment with the situation one year ago, when tariff concerns caused small caps to fall out of favor. Since then, he notes a shift toward stability that allows companies to plan and invest. Based on his visits with companies since the start of the year, he observes tremendous excitement and expansion, driven by over $700 billion in spending from hyperscalers. Retzler explained that because one company’s CapEx becomes another’s revenue, this spending filters down to the smaller companies supplying these buildouts.
Retzler clarified that the growth in the Russell 2000 is not necessarily coming from consumer-based companies, which he acknowledged are weaker due to higher oil prices and interest rates. Instead, the growth is driven by beneficiaries of AI, infrastructure buildouts, and military modernization. He emphasized that global tensions necessitate investment in areas like drones and hypersonic missiles, and he noted that the companies he visits are hiring and expanding in a way he has not seen in a long time. When asked if investors should buy the entire index or specific sectors, Retzler noted that he manages a concentrated portfolio focused on companies with strong technological moats. He mentioned that his fund is up approximately 74% this year, largely due to exposure to semiconductor capital equipment, infrastructure, and military modernization. While he believes these trends can continue, he advises trimming positions that have performed well and rotating into names that have not, particularly noting that consumer-facing stocks have been an area of weakness.
Our Methodology
We used screeners to identify stocks that are trading below $5 per share and have an average upside potential of at least 30%. We limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among elite hedge funds and are ranked in ascending order of their upside potential.
Note: All data was sourced on June 2.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).
10 Most Promising Penny Stocks According to Wall Street Analysts
10. Newell Brands Inc. (NASDAQ:NWL)
Average Upside Potential: 38.04%
Newell Brands Inc. (NASDAQ:NWL) is one of the most promising penny stocks according to Wall Street analysts. On June 2, Newell Brands announced a €40 million investment in its French operations over the next three years, revealed during the 2026 Choose France Summit. This capital infusion is designed to enhance the global competitiveness of the company’s French manufacturing and business network, which currently employs nearly 1,000 people across the country.
The investment will be distributed across four key strategic pillars: advanced manufacturing automation, a digitization program utilizing artificial intelligence to optimize safety and quality, infrastructure and sustainability upgrades, and a dedicated workforce development initiative focused on upskilling and leadership training.
As one of Newell Brands Inc.’s (NASDAQ:NWL) top ten international markets with over a century of local history, France remains a cornerstone of the company’s international growth strategy. By modernizing its local sites and processes, the company aims to build a more agile and sustainable operation for its iconic brands, such as Spontex, Campingaz, Parker, and Waterman.
Newell Brands Inc. is an American consumer goods company with a strong portfolio of brands such as Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer’s, Oster, NUK, Spontex, and Campingaz.
9. Burford Capital Ltd. (NYSE:BUR)
Average Upside Potential: 40.14%
Burford Capital Ltd. (NYSE:BUR) is one of the most promising penny stocks according to Wall Street analysts. On May 8, Burford Capital announced the appointment of Travis Lenkner as Chief Operating Officer/COO. Previously serving as the firm’s Chief Development Officer, Lenkner will now oversee execution and operating performance across all business units while retaining his responsibilities for global business development, marketing, and corporate strategy. He will also co-chair the firm’s Operating Committee alongside CFO Jordan Licht.
Lenkner brings a wealth of experience in legal finance and complex litigation, having previously been a managing director at Burford following their acquisition of Gerchen Keller Capital. His career also includes leadership roles in private legal practice, in-house counsel experience at The Boeing Company, and clerkships for the U.S. Supreme Court and the US Court of Appeals for the D.C. Circuit.
Additionally, the firm has promoted Carrie Tendler to Managing Director and Head of its Asset Recovery team. Tendler, who joined the firm in 2024, has been instrumental in enforcing judgments for Burford-backed matters. Her background includes serving as a partner at Kobre & Kim and practicing at Cravath, Swaine & Moore LLP, further strengthening the leadership team as the firm focuses on continued business growth and execution.
Burford Capital Ltd. provides legal finance goods and services globally. Its services include providing capital against the high-value litigation and arbitration cases, legal risk management, managing legal finance assets on behalf of third-party investors, and providing other services to the legal industry.
8. Tuya Inc. (NYSE:TUYA)
Average Upside Potential: 60.29%
Tuya Inc. (NYSE:TUYA) is one of the most promising penny stocks according to Wall Street analysts. On May 11, Tuya reported total revenue of $80.9 million for Q1 2026, representing an 8.3% year-over-year increase. Growth was driven primarily by its Platform-as-a-Service/PaaS segment, which rose 9.8% to $59.0 million, and its “AI application & others” division, which grew 16.9% to $11.6 million. While the company saw improved GAAP operating and net margins (reaching 9.2% and 19.5% respectively), the overall gross margin experienced a slight decline to 46.9%.
Operating results remain anchored by a robust developer ecosystem, with the number of registered AI developers growing to over 1.97 million. The company is actively rebranding its segments to better reflect a strategic pivot toward AI-integrated software and AI-enabled consumer hardware, such as home robotics and smart security systems. This shift is intended to accelerate the commercialization of its “Physical AI” capabilities and subscription-based value-added services.
Financially, Tuya remains in a strong position, maintaining over $1.0 billion in cash and liquid investments as of March 31. Management emphasized that this liquidity provides the necessary flexibility to continue investing in global expansion and AI-driven product innovation, despite ongoing regional market uncertainties. Tuya Inc. expects to continue utilizing its platform efficiency to drive further commercial scale throughout the remainder of the year.
Tuya Inc. provides AI cloud platform services in the People’s Republic of China. The company has a partnership with Shanghai Luobo Intelligent Technology Co., Ltd. for the development of an AI companion powered by cellular connectivity.
7. CCC Intelligent Solutions Holdings Inc. (NASDAQ:CCC)
Average Upside Potential: 60.32%
CCC Intelligent Solutions Holdings Inc. (NASDAQ:CCC) is one of the most promising penny stocks according to Wall Street analysts. On April 30, CCC Intelligent Solutions announced that Brian Herb, Executive Vice President and Chief Financial & Administrative Officer, will depart the company on May 25 to pursue a new opportunity. Following his exit, Rodney Christo, the current Senior VP of Finance and Chief Accounting Officer, will step in as interim CFO while the company searches for a permanent successor. Herb will remain with the firm as an advisor for a period following his departure.
In conjunction with this leadership update, CCC Intelligent Solutions reported strong financial results for Q1 2026. The company generated $281.3 million in revenue, representing a 12% increase compared to the same period in 2025. Furthermore, adjusted EBITDA reached $120.2 million, a 21% growth from the $99.1 million reported in the first quarter of the previous year.
CEO Githesh Ramamurthy praised Herb’s contributions while expressing confidence in the transition, noting that Christo’s 30-year tenure with the company ensures continuity in financial operations. CCC Intelligent Solutions Holdings Inc. continues to utilize its SaaS and AI platform to serve the insurance industry, focusing on maintaining its current growth trajectory and strategic execution.
CCC Intelligent Solutions Holdings Inc. serves property and casualty (“P&C”) insurance companies with cloud, mobile, telematics, hyperscale technologies, and applications, including a cloud-based software as a service platform for digitized workflows.
6. SEALSQ Corp. (NASDAQ:LAES)
Average Upside Potential: 61.73%
SEALSQ Corp. (NASDAQ:LAES) is one of the most promising penny stocks according to Wall Street analysts. On June 2, SEALSQ acquired a majority stake in Wecan Group and committed CHF 5 million to develop AI-driven, post-quantum compliance solutions. This initiative integrates quantum-resistant cryptography and secure hardware into financial workflows to protect sensitive data against future computing threats.
The partnership will launch an AI “Compliance Co-Pilot” to automate onboarding, transaction monitoring, and KYC processes. By incorporating WISeKey’s digital identity ecosystem, the platform provides banks and digital asset providers with a unified, quantum-secure infrastructure for transaction signing and identity management.
This investment strengthens SEALSQ Corp.’s (NASDAQ:LAES) position in cybersecurity and regulated financial infrastructure. By combining hardware-backed authentication with Wecan Group’s banking expertise, the companies aim to provide a scalable, future-ready solution for the evolving tokenized economy.
SEALSQ Corp. is involved in the security of microcontrollers. The company’s operations are divided into the following geographical segments: North America, Europe, the Middle East, Africa, Asia Pacific, and Latin America.
5. VinFast Auto Ltd. (NASDAQ:VFS)
Average Upside Potential: 77.51%
VinFast Auto Ltd. (NASDAQ:VFS) is one of the most promising penny stocks according to Wall Street analysts. On June 1, VinFast, Autobrains, and NVIDIA announced a collaboration to develop a Level 4 autonomous driving program tailored specifically for Southeast Asia’s complex traffic environments. Built on the NVIDIA DRIVE Hyperion 10 platform, the project utilizes Autobrains’ “Agentic AI,” which employs specialized AI agents to handle real-world driving tasks more efficiently than traditional end-to-end models.
This partnership aims to overcome the industry’s persistent barriers to autonomy: high compute costs, excessive system complexity, and brittle performance. By using a modular architecture and Agentic AI, the companies plan to deliver advanced autonomous capabilities without the premium price tags that have previously hindered mass deployment in the region.
The initiative uses NVIDIA’s hardware foundation to accelerate development timelines and reduce integration efforts. For VinFast Auto Ltd., this program is a core component of its strategy to make smart electric vehicle technologies more accessible and scalable, ensuring reliable autonomous performance in dynamic urban settings while maintaining a cost-efficient path to market.
VinFast Auto Ltd. designs and manufactures electric vehicles. It offers electric scooters (e-scooters) and electric buses (e-buses). It provides an e-mobility ecosystem built around customers, community, and connectivity alongside new vehicle roll-out.
4. MannKind Corporation (NASDAQ:MNKD)
Average Upside Potential: 104.08%
MannKind Corporation (NASDAQ:MNKD) is one of the most promising penny stocks according to Wall Street analysts. On June 3, MannKind reached key milestones in its clinical program for nintedanib DPI, a dry powder inhalation therapy for idiopathic pulmonary fibrosis/IPF. The company has completed patient randomization for its US Phase 1b INFLO-1 trial and successfully enrolled the first participant in its global Phase 2 INFLO-2 study. Data from the INFLO-1 trial is expected in Q3 2026.
The nintedanib DPI program utilizes MannKind’s proprietary Technosphere technology to deliver medication directly to the lungs. By targeting the site of the disease, the company aims to maintain antifibrotic efficacy while minimizing the systemic side effects often associated with the currently approved oral form of nintedanib. This approach is designed to improve treatment tolerability, long-term adherence, and the potential for combination therapies in patients with IPF.
The Phase 2 INFLO-2 trial is a randomized, double-blind study designed to evaluate the safety, tolerability, and optimal dosing of nintedanib DPI in ~210 participants across 85 global sites. Following a 12-week treatment period, the study includes a 24-week open-label extension to assess secondary efficacy endpoints, including lung function and patient-reported outcomes, further defining the therapy’s potential as a new standard of care for the condition.
MannKind Corporation is a biopharmaceutical company focused on developing and commercializing innovative inhaled therapeutic products and devices for those living with endocrine and orphan lung diseases.
3. Eve Holding Inc. (NYSE:EVEX)
Average Upside Potential: 107.10%
Eve Holding Inc. (NYSE:EVEX) is one of the most promising penny stocks according to Wall Street analysts. On May 5, Eve Holding reported a net loss of $68.8 million for Q1 2026, up from $48.8 million in the same period last year. As a pre-operational company, these results reflect intensified R&D expenses, which rose to $59.1 million. This increase is driven by ongoing eVTOL aircraft development, expanded supplier engagement, and critical engineering support provided by Embraer under its Master Service Agreement.
Despite the rise in R&D costs, the company saw a slight decrease in Selling, General & Administrative expenses to $7.2 million. The company’s total cash consumption reached $68.6 million for the quarter, or $57 million when adjusted for a deferred payment to Embraer. This higher spend aligns with the acceleration of design and development activities as the company scales its workforce and infrastructure.
Eve Holding Inc. ended the quarter with a record liquidity position of $577.7 million, including $441.1 million in cash and financial investments and a new $150 million syndicated loan secured in January. This is sufficient to support the company’s planned operations and program investments through 2028 as it continues to develop its eVTOL aircraft and urban air mobility ecosystem.
Eve Holding Inc. is a creator of urban air mobility solutions. It is engaged in the design and manufacturing of electric vertical take-off and landing (eVTOL) aircraft. It also provides eVTOL and support services, which include technical support, training, maintenance, data services, and ground handling.
2. OPKO Health Inc. (NASDAQ:OPK)
Average Upside Potential: 114.29%
OPKO Health Inc. (NASDAQ:OPK) is one of the most promising penny stocks according to Wall Street analysts. On April 30, OPKO Health amended its agreement with Nicoya Therapeutics to grant OPKO a 15% equity interest in the firm, deepening its partnership to commercialize RAYALDEE in Greater China. While the equity stake modifies the royalty and transfer price schedule, the original milestone structure remains intact, keeping OPKO eligible for up to $115 million in potential development, regulatory, and sales-based payments.
Nicoya, a specialist in the Chinese nephrology market, is currently working to bring RAYALDEE to patients suffering from secondary hyperparathyroidism associated with chronic kidney disease. With the treatment already approved in Macau, both companies are targeting further regulatory approvals across China and its related territories in 2027 to address the needs of an estimated 20 million adults affected by stage 3 or 4 chronic kidney disease in the region.
This collaboration uses OPKO Health Inc.’s (NASDAQ:OPK) integrated manufacturing and supply chain capabilities alongside Nicoya’s localized clinical and commercial expertise. Management noted that the expansion of this agreement aligns with the broader strategy to increase global patient access to RAYALDEE, representing a significant growth opportunity for both companies within the large and underserved Asian renal health market.
OPKO Health Inc. is a multinational biopharmaceutical and diagnostics company that discovers, develops, and commercializes pharmaceutical products and operates clinical laboratories. It focuses on treating serious diseases through products such as RAYALDEE and NGENLA, while also providing diagnostic services.
1. Alvotech (NASDAQ:ALVO)
Average Upside Potential: 135.51%
Alvotech (NASDAQ:ALVO) is one of the most promising penny stocks according to Wall Street analysts. On May 11, Alvotech announced the completion of a routine FDA surveillance inspection at its manufacturing facility in Reykjavik, Iceland. While the FDA issued a Form 483 at the conclusion of the visit on May 8, 2026, the company stated that it believes the observations are manageable and do not indicate significant issues with the site’s overall operations or compliance.
Management views the results as a validation of the facility’s current cGMP fundamentals and the effectiveness of improvements implemented over the past year. Consequently, the company remains on schedule to resubmit its relevant BLAs during Q2 2026.
Alvotech maintains its outlook for achieving FDA approval for these BLAs within the 2026 calendar year. The company continues to focus on finalizing the necessary data compilation to support the upcoming regulatory submissions.
Alvotech is a biotechnology company that develops and manufactures biosimilar medicines. The firm’s focus is on the development of its product candidates, with its operations divided into the following geographical segments: Europe, North America, Asia, and Other.
READ NEXT: 10 Best Low Priced Stocks to Buy for the Next 3 Years and 12 Best Low Priced Growth Stocks to Invest In Now.
Follow Insider Monkey on Google News.
